SCHEMBL1668629

SCHEMBL1668629

CS(=O)(=O)N1CCC(c2cc(F)c(OC3CN(Cc4ncc(C(F)(F)F)cc4Cl)C3)c(F)c2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 1/20 0.37
MMP2 P08253 1/20 0.37
ADAM17 P78536 1/20 0.37
IDO1 P14902 2/20 0.37
FPR2 P25090 1/20 0.35
PROKR1 Q8TCW9 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
KMT2A Q03164 2/20 0.35
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
GRM2 Q14416 1/20 0.34
GPR119 Q8TDV5 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RORC P51449 1/20 0.34
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
CCND3 P30281 1/20 0.34
CDK6 Q00534 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1668540 0.87 IDO1 (0.39) IDO1FPR2PROKR1KMT2AGPR119
SCHEMBL12198362 0.86 TDP1 (0.39) L3MBTL1TDP1KMT2ADRD2DRD4
SCHEMBL1668410 0.83 KDM4E (0.49) KMT2AGPR119RORCLMNA
SCHEMBL1668262 0.78 KDM4E (0.48) KMT2AGPR119RORCLMNA
SCHEMBL1668617 0.77 KDM4E (0.41) IDO1KMT2ADRD2DRD4DRD3
SCHEMBL1668609 0.77 FPR2 (0.37) IDO1FPR2PROKR1KMT2ADRD2
SCHEMBL12198265 0.77 KDM4E (0.41) IDO1KMT2AGPR119RORCLMNA
SCHEMBL1669062 0.76 SCN8A (0.40) IDO1FPR2PROKR1KMT2ADRD2
SCHEMBL1668891 0.76 GPR119 (0.48) IDO1KMT2AGPR119RORCLMNA
SCHEMBL1669079 0.76 LMNA (0.38) IDO1FPR2PROKR1KMT2AGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US claimed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP claimed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US claimed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO claimed
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US disclosed
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US disclosed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP disclosed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US disclosed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 ADAMTS4 4320/4885MMP2 4245/4885ADAM17 3407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.